LT4393545T - Nauji piperidinilindolo darinių naudojimo būdai - Google Patents

Nauji piperidinilindolo darinių naudojimo būdai

Info

Publication number
LT4393545T
LT4393545T LTEP24170648.0T LT24170648T LT4393545T LT 4393545 T LT4393545 T LT 4393545T LT 24170648 T LT24170648 T LT 24170648T LT 4393545 T LT4393545 T LT 4393545T
Authority
LT
Lithuania
Prior art keywords
piperidinyl
indole derivatives
novel uses
novel
indole
Prior art date
Application number
LTEP24170648.0T
Other languages
English (en)
Inventor
Jörg EDER
Richard Alexander Harrison
Boerje Haraldsson
Anna Svenja Schubart
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LT4393545T publication Critical patent/LT4393545T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LTEP24170648.0T 2017-08-31 2018-08-30 Nauji piperidinilindolo darinių naudojimo būdai LT4393545T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17188870 2017-08-31

Publications (1)

Publication Number Publication Date
LT4393545T true LT4393545T (lt) 2026-01-12

Family

ID=59745840

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEPPCT/IB2018/056618T LT3675854T (lt) 2017-08-31 2018-08-30 Piperidinilindolo dariniai, skirti c3 glomerulopatijai gydyti
LTEP24170648.0T LT4393545T (lt) 2017-08-31 2018-08-30 Nauji piperidinilindolo darinių naudojimo būdai

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEPPCT/IB2018/056618T LT3675854T (lt) 2017-08-31 2018-08-30 Piperidinilindolo dariniai, skirti c3 glomerulopatijai gydyti

Country Status (22)

Country Link
US (3) US11723901B2 (lt)
EP (3) EP3675854B1 (lt)
JP (3) JP6754919B1 (lt)
KR (3) KR102497487B1 (lt)
CN (5) CN117338783A (lt)
AU (1) AU2018326768B2 (lt)
BR (1) BR112020003737A2 (lt)
CA (1) CA3073346A1 (lt)
CL (1) CL2020000483A1 (lt)
DK (2) DK4393545T3 (lt)
ES (2) ES3058507T3 (lt)
FI (2) FI3675854T3 (lt)
HR (2) HRP20251596T1 (lt)
HU (1) HUE071118T2 (lt)
IL (1) IL272888B2 (lt)
LT (2) LT3675854T (lt)
MX (3) MX2020002185A (lt)
PL (2) PL4393545T3 (lt)
PT (2) PT4393545T (lt)
RS (2) RS66635B1 (lt)
SI (2) SI3675854T1 (lt)
WO (1) WO2019043609A1 (lt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3675854T1 (sl) 2017-08-31 2025-05-30 Novartis Ag Derivati piperidinil-indola za uporabo v zdravljenju glomerulopatije c3
US20230064254A1 (en) * 2019-12-19 2023-03-02 Taiho Pharmaceutical Co., Ltd. Therapeutic agent containing fused pyrimidine compound as active ingredient
TW202504893A (zh) 2020-05-18 2025-02-01 瑞士商諾華公司 Lnp023之結晶形式
EP4194449A4 (en) * 2020-08-07 2024-03-20 Shanghai Meiyue Biotech Development Co., Ltd. Heterocyclic compound, preparation method therefor and use thereof
CN114057758A (zh) 2020-08-07 2022-02-18 上海美悦生物科技发展有限公司 补体因子b抑制剂及其药物组合物、制备方法和用途
WO2022143940A1 (zh) * 2020-12-30 2022-07-07 南京明德新药研发有限公司 一系列哌啶取代的苯酸类化合物及其应用
WO2022143845A1 (zh) 2020-12-30 2022-07-07 江苏恒瑞医药股份有限公司 含氮桥杂环化合物、其制备方法及其在医药上的应用
EP4333845A1 (en) * 2021-05-07 2024-03-13 Novartis AG Iptacopan for the treatment of atypical hemolytic uremic syndrome
JP2024532847A (ja) 2021-08-18 2024-09-10 シーザン ハイスーク ファーマシューティカル カンパニー リミテッド ベンズアゼピン芳香環誘導体及びその医薬的な応用
US20250243186A1 (en) * 2021-10-27 2025-07-31 Hansoh Bio Llc Piperidinyl indole derivatives, preparation methods and medicinal uses thereof
CA3247772A1 (en) * 2022-01-24 2023-07-27 Novartis Ag Spirocyclic piperidinyl derivatives as complement factor B inhibitors and their uses
CA3242815A1 (en) * 2022-01-26 2023-08-03 Shanghai Meiyue Biotech Development Co., Ltd. Salt type and crystal form of complement factor b inhibitor, and preparation method therefor and application thereof
WO2023237041A1 (zh) * 2022-06-10 2023-12-14 正大天晴药业集团股份有限公司 双环取代的芳香羧酸酯类化合物
CN119698414A (zh) * 2022-06-20 2025-03-25 深圳信立泰药业股份有限公司 一种吲哚-苯基哌啶化合物及其制备方法与应用
CN117327070A (zh) * 2022-06-30 2024-01-02 江苏恒瑞医药股份有限公司 一种含氮桥杂环衍生物的晶型及其制备方法
JP7849520B2 (ja) 2022-06-30 2026-04-21 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 含窒素架橋複素環誘導体の薬学的に許容される塩、結晶形及びその調製方法
CA3266935A1 (en) * 2022-09-10 2024-03-14 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Piperidine derivatives substituted at position 2, their preparation methods and medicinal uses
EP4617266A1 (en) 2022-11-11 2025-09-17 Shanghai Yisheng Biopharmaceutical company Limited Piperidine-substituted benzoic acid compound, and pharmaceutical composition and use thereof
JP2026502231A (ja) * 2022-12-31 2026-01-21 チューハイ ユナイテッド ラボラトリーズ シーオー．，エルティーディー． 補体因子ｂ阻害剤、その医薬組成物および使用
CN119371402A (zh) 2023-07-26 2025-01-28 上海美悦生物科技发展有限公司 螺环烯基类或氮杂烯基类化合物及其药物组合物、制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192742B2 (en) * 2007-03-23 2012-06-05 NovelMed Therapeutics Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof
JP6214647B2 (ja) 2012-06-28 2017-10-18 ノバルティス アーゲー 補体経路モジュレーターおよびその使用
EP2970269B1 (en) * 2013-03-14 2017-04-19 Novartis AG 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
JO3425B1 (ar) * 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
MX2018007392A (es) 2015-12-23 2018-08-15 Greenovation Biotech Gmbh Polipeptidos para inhibir la activacion del complemento.
US10736960B2 (en) * 2016-01-05 2020-08-11 Omeros Corporation Methods for inhibiting fibrosis in a subject in need thereof
SI3675854T1 (sl) 2017-08-31 2025-05-30 Novartis Ag Derivati piperidinil-indola za uporabo v zdravljenju glomerulopatije c3
TW202504893A (zh) 2020-05-18 2025-02-01 瑞士商諾華公司 Lnp023之結晶形式
US11951101B2 (en) 2020-07-16 2024-04-09 Novartis Ag Methods of using factor B inhibitors

Also Published As

Publication number Publication date
FI3675854T3 (fi) 2025-04-07
HRP20251596T1 (hr) 2026-01-30
PL3675854T3 (pl) 2025-05-19
IL272888B1 (en) 2023-09-01
US20250195493A1 (en) 2025-06-19
JP7297016B2 (ja) 2023-06-23
LT3675854T (lt) 2025-04-25
FI4393545T3 (fi) 2026-01-14
JP6929425B2 (ja) 2021-09-01
KR102682887B1 (ko) 2024-07-08
JP2021181471A (ja) 2021-11-25
MX2023010751A (es) 2023-09-20
US11723901B2 (en) 2023-08-15
CN117398384A (zh) 2024-01-16
AU2018326768A1 (en) 2020-02-06
US20220152011A1 (en) 2022-05-19
EP3675854A1 (en) 2020-07-08
ES3022885T3 (en) 2025-05-29
HRP20250386T1 (hr) 2025-05-23
KR20230024432A (ko) 2023-02-20
BR112020003737A2 (pt) 2020-09-01
US12285422B2 (en) 2025-04-29
EP3675854B1 (en) 2025-01-22
RS67530B1 (sr) 2026-01-30
CN117338783A (zh) 2024-01-05
PL4393545T3 (pl) 2026-03-16
MX2023010750A (es) 2023-09-20
MX2020002185A (es) 2020-07-14
EP4647121A3 (en) 2026-02-18
AU2018326768B2 (en) 2021-07-29
EP4393545A2 (en) 2024-07-03
SI4393545T1 (sl) 2026-02-27
HUE071118T2 (hu) 2025-08-28
WO2019043609A1 (en) 2019-03-07
JP2020193222A (ja) 2020-12-03
EP4647121A2 (en) 2025-11-12
JP2020529466A (ja) 2020-10-08
CA3073346A1 (en) 2019-03-07
RU2020111788A (ru) 2021-09-30
EP4393545B1 (en) 2025-10-08
JP6754919B1 (ja) 2020-09-16
CL2020000483A1 (es) 2020-09-04
KR102497487B1 (ko) 2023-02-08
RU2020111788A3 (lt) 2021-12-28
KR20200047540A (ko) 2020-05-07
DK4393545T3 (da) 2026-01-12
ES3058507T3 (en) 2026-03-11
PT4393545T (pt) 2025-12-23
PT3675854T (pt) 2025-04-04
CN117338782A (zh) 2024-01-05
SI3675854T1 (sl) 2025-05-30
RS66635B1 (sr) 2025-04-30
DK3675854T3 (da) 2025-04-07
IL272888A (en) 2020-04-30
CN111032042A (zh) 2020-04-17
CN117338781A (zh) 2024-01-05
EP4393545A3 (en) 2024-09-25
US20200338059A1 (en) 2020-10-29
IL272888B2 (en) 2024-01-01
KR20240111007A (ko) 2024-07-16

Similar Documents

Publication Publication Date Title
IL272888A (en) Uses of piperidinyl-indole derivatives
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
IL271607B1 (en) New azaquinoline histories
SG11201706729SA (en) Derivatives of sobetirome
PL3645518T3 (pl) Synteza omekamtywu mekarbilu
HUE056357T2 (hu) Szobetirom származékok
IL269409A (en) Combinations of chk1- and wee1 - inhibitors
IL276592A (en) History of Subtirum
IL274627A (en) Solid forms of valbenazine
IL272697A (en) A polymorphic form of TG02
PT3661491T (pt) 3-metilmetcatinona para uso no tratamento de um indivíduo sob uma intervenção psicoterapêutica
IL265628A (en) Solid state forms of valbenazine
IL272857A (en) Cofanalisib formulations
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
IL270961A (en) Crystalline form of N-butyldeoxygalactonogirimycin
EP3468578A4 (en) USES OF IL-41
IL270703A (en) History of Reziquimod
PT3395819T (pt) Forma cristalina de derivado de aminopirano substituído
IL263363A (en) Polymorph of nintedanib
IL254666A0 (en) Crystalline forms of Aldecalcitol
GB201721386D0 (en) Chrondogy of time-wave
IL270937A (en) Crystalline forms of saltalicib
AU2017904670A0 (en) Improvement of clothes-hangers
HK40006442A (en) Derivatives of sobetirome
HK40007680A (en) N-carboxyanhydride-based-scale synthesis of elamipretide